Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cd34+ cells enriched with mnv-bld (1 trial)
mnv-201 (1 trial)
mnv-bm-plc (1 trial)
Lipid Metabolism, Inborn Errors (Phase 1)
Mitochondrial Diseases (Phase 1)
Muscular Diseases (Phase 1)
Syndrome (Phase 1)
Trials (3 total)
Trial APIs (3 total)